Superiority and equivalence in thrombolytic drugs: an interpretation.
Walley
T
T
Department of Pharmacology and Therapeutics, University of Liverpool, UK. twalley@liv.ac.uk
Dundar
Y
Y
Hill
R
R
Dickson
R
R
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use; D000077785:Tenecteplase; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; C087896:reteplase; D013300:Streptokinase; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase